DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Ziprasidone hydrochlorideis the generic ingredient in two branded drugs marketed by Upjohn, Apotex, Aurobindo Pharma Ltd, Cadila, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan, Sandoz Inc, Wockhardt Ltd, and Pfizer Inc, and is included in eleven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Ziprasidone hydrochloride has fifty-nine patent family members in forty-nine countries.
There are twenty-three drug master file entries for ziprasidone hydrochloride. Twenty-three suppliers are listed for this compound.
Summary for ziprasidone hydrochloride
Recent Clinical Trials for ziprasidone hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Shanghai Jiao Tong University School of Medicine||Phase 4|
|Shanghai Mental Health Center||Phase 4|
|University of Arizona||Phase 1|
Pharmacology for ziprasidone hydrochloride
|Drug Class||Atypical Antipsychotic |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Lupin Pharms||ZIPRASIDONE HYDROCHLORIDE||ziprasidone hydrochloride||CAPSULE;ORAL||077560-002||Mar 2, 2012||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Dr Reddys Labs Inc||ZIPRASIDONE HYDROCHLORIDE||ziprasidone hydrochloride||CAPSULE;ORAL||077565-001||Mar 2, 2012||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Apotex||ZIPRASIDONE HYDROCHLORIDE||ziprasidone hydrochloride||CAPSULE;ORAL||077561-002||Mar 2, 2012||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Upjohn||GEODON||ziprasidone hydrochloride||CAPSULE;ORAL||020825-001||Feb 5, 2001||AB||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Upjohn||GEODON||ziprasidone hydrochloride||CAPSULE;ORAL||020825-002||Feb 5, 2001||Start Trial||Start Trial|
|Pfizer Inc||GEODON||ziprasidone hydrochloride||SUSPENSION;ORAL||021483-001||Mar 29, 2006||Start Trial||Start Trial|
|Upjohn||GEODON||ziprasidone hydrochloride||CAPSULE;ORAL||020825-004||Feb 5, 2001||Start Trial||Start Trial|
|Upjohn||GEODON||ziprasidone hydrochloride||CAPSULE;ORAL||020825-001||Feb 5, 2001||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.